Isolation of cytomegalovirus (CMV) specific T-cells from sersopositve donors: A possible tool for CMV-prophylaxis.

被引:0
|
作者
Borchers, S
Topp, M
Ganser, A
Einsele, H
Weissinger, EM
Hertenstein, B
机构
[1] Hannover Med Sch, D-3000 Hannover, Germany
[2] Univ Wurzburg, Wurzburg, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3037
引用
收藏
页码:850A / 850A
页数:1
相关论文
共 50 条
  • [31] Safety and preliminary efficacy of "Ready to administer" cytomegalovirus (CMV)-specific T cells for the treatment of patients with refractory CMV infection
    Tzannou, I.
    Kakarla, S.
    Watanabe, A.
    Leung, K. S.
    Martinez, C.
    Naik, S.
    Gottschalk, S.
    Gee, A. P.
    Grilley, B.
    Giroir, B.
    Vera, J. F.
    Leen, A. M.
    Omer, B.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S507 - S507
  • [32] CYTOMEGALOVIRUS (CMV) SPECIFIC CYTOTOXIC T LYMPHOCYTES FROM A CMV SERO-NEGATIVE DONOR FOR PERSISTENT CMV INFECTION POST-TRANSPLANT
    Lucas, K.
    Cowan, M.
    Horn, B.
    Dunham, K.
    Bao, L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 100 - 100
  • [33] Cytomegalovirus (CMV)-Specific T Cells as a Parameter for Individual CMV-Specific Immune Response after Pediatric Kidney Transplantation (Tx)
    Ahlenstiel, T.
    Sester, U.
    Sester, M.
    Pape, L.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1810 - 1810
  • [34] EFFICIENT INDUCTION AND ISOLATION OF A PRIMARY CMV-SPECIFIC CD8+T CELL RESPONSE FROM CMV SERONEGATIVE DONORS FOR THE TREATMENT OF SERIOUS CMV-RELATED COMPLICATIONS IN CMV SEROPOSITIVE PATIENTS TRANSPLANTED WITH A CMV SERONEGATIVE DONOR
    Jedema, I
    van de Meeent, M.
    van der Heiden, P. L. J.
    Marijit, E. W. A.
    Meij, P.
    Willemze, R.
    Falkenburg, J. H. F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 104 - 105
  • [35] Ex vivo stimulation of cytomegalovirus (CMV)-specific T cells using CMV pp65-modified dendritic cells as stimulators
    Carlsson, B
    Cheng, WS
    Tötterman, TH
    Essand, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (03) : 428 - 438
  • [36] SIGNATURE PROFILES OF CMV-SPECIFIC T-CELLS IN PATIENTS WITH CMV REACTIVATION AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Kalina, Tomas
    Krol, Ladislav
    Stuchly, Jan
    Keslova, Petra
    Hubacek, Petr
    Sedlacek, Petr
    Stary, Jan
    Ondrej, Hrusak
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2010, 78B (06) : 409 - 409
  • [37] Extending the Option of CMV-Specific T Cells from the CMV-Seronegative Donor
    Hanley, Patrick J.
    Nikiforow, Sarah
    Melenhorst, Jan
    Scheinberg, Phillip
    Savoldo, Barbara
    Dotti, Gianpietro
    Rooney, Cliona M.
    Heslop, Helen E.
    Shpall, Elizabeth J.
    Barrett, A. John
    Bollard, Catherine M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S131 - S131
  • [38] Efficient induction and isolation of primary CMV-specific CD8+ T-cell responses from CMV seronegative donors for the treatment of serious CMV-related complications in CMV seropositive patients transplanted with a CMV seronegative donor
    Jedema, I.
    De Meent, M. Van
    Van der Heiden, P. L. J.
    Marijt, W. A. F.
    Meij, P.
    Willemze, R.
    Falkenburg, J. H. F.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S160 - S160
  • [39] Cytomegalovirus (CMV) Epitope-Specific CD4+ T Cells Are Inflated in HIV+ CMV+ Subjects
    Abana, Chike O.
    Pilkinton, Mark A.
    Gaudieri, Silvana
    Chopra, Abha
    McDonnell, Wyatt J.
    Wanjalla, Celestine
    Barnett, Louise
    Gangula, Rama
    Hager, Cindy
    Jung, Dae K.
    Engelhardt, Brian G.
    Jagasia, Madan H.
    Klenerman, Paul
    Phillips, Elizabeth J.
    Koelle, David M.
    Kalams, Spyros A.
    Mallal, Simon A.
    JOURNAL OF IMMUNOLOGY, 2017, 199 (09): : 3187 - 3201
  • [40] Isolation of donor derived CMV specific T-cells for the treatment of CMV disease in patients after in-vitro T-cell-depleted allogeneic stem cell transplantation
    Jedema, I
    Cox, LMP
    Meij, P
    Barge, RMY
    Willemze, R
    Falkenburg, JHF
    BONE MARROW TRANSPLANTATION, 2005, 35 : S26 - S26